Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

NLRP2 Regulates Proinflammatory and Antiapoptotic Responses in Proximal Tubular Epithelial Cells.

Rossi MN, Pascarella A, Licursi V, Caiello I, Taranta A, Rega LR, Levtchenko E, Emma F, De Benedetti F, Prencipe G.

Front Cell Dev Biol. 2019 Oct 24;7:252. doi: 10.3389/fcell.2019.00252. eCollection 2019.

2.

Ofatumumab rescue treatment in post-transplant recurrence of focal segmental glomerulosclerosis.

Colucci M, Labbadia R, Vivarelli M, Camassei FD, Emma F, Dello Strologo L.

Pediatr Nephrol. 2019 Oct 30. doi: 10.1007/s00467-019-04365-w. [Epub ahead of print]

PMID:
31667616
3.

SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder.

Del Dotto V, Ullah F, Di Meo I, Magini P, Gusic M, Maresca A, Caporali L, Palombo F, Tagliavini F, Baugh EH, Macao B, Szilagyi Z, Peron C, Gustafson MA, Khan K, La Morgia C, Barboni P, Carbonelli M, Valentino ML, Liguori R, Shashi V, Sullivan J, Nagaraj S, El-Dairi M, Iannaccone A, Cutcutache I, Bertini E, Carrozzo R, Emma F, Diomedi-Camassei F, Zanna C, Armstrong M, Page M, Stong N, Boesch S, Kopajtich R, Wortmann S, Sperl W, Davis EE, Copeland WC, Seri M, Falkenberg M, Prokisch H, Katsanis N, Tiranti V, Pippucci T, Carelli V.

J Clin Invest. 2019 Nov 18. pii: 128514. doi: 10.1172/JCI128514. [Epub ahead of print]

4.

Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome.

Colucci M, Carsetti R, Serafinelli J, Rocca S, Massella L, Gargiulo A, Lo Russo A, Capponi C, Cotugno N, Porzio O, Onetti Muda A, Palma P, Emma F, Vivarelli M.

Front Immunol. 2019 Jul 16;10:1653. doi: 10.3389/fimmu.2019.01653. eCollection 2019.

5.

Atypical IgM on T cells predict relapse and steroid dependence in idiopathic nephrotic syndrome.

Colucci M, Carsetti R, Rosado MM, Cascioli S, Bruschi M, Candiano G, Corpetti G, Giardino L, Serafinelli J, Giannone C, Ghiggeri GM, Rastaldi MP, Sitia R, Emma F, Vivarelli M.

Kidney Int. 2019 Oct;96(4):971-982. doi: 10.1016/j.kint.2019.04.006. Epub 2019 May 7.

PMID:
31285081
6.

X-linked hypophosphatemic rickets: an Italian experts' opinion survey.

Emma F, Cappa M, Antoniazzi F, Bianchi ML, Chiodini I, Eller Vainicher C, Di Iorgi N, Maghnie M, Cassio A, Balsamo A, Baronio F, de Sanctis L, Tessaris D, Baroncelli GI, Mora S, Brandi ML, Weber G, D'Ausilio A, Lanati EP.

Ital J Pediatr. 2019 May 31;45(1):67. doi: 10.1186/s13052-019-0654-6.

7.

International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people.

Gimpel C, Bergmann C, Bockenhauer D, Breysem L, Cadnapaphornchai MA, Cetiner M, Dudley J, Emma F, Konrad M, Harris T, Harris PC, König J, Liebau MC, Marlais M, Mekahli D, Metcalfe AM, Oh J, Perrone RD, Sinha MD, Titieni A, Torra R, Weber S, Winyard PJD, Schaefer F.

Nat Rev Nephrol. 2019 Nov;15(11):713-726. doi: 10.1038/s41581-019-0155-2. Review.

PMID:
31118499
8.

Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.

Haffner D, Emma F, Eastwood DM, Duplan MB, Bacchetta J, Schnabel D, Wicart P, Bockenhauer D, Santos F, Levtchenko E, Harvengt P, Kirchhoff M, Di Rocco F, Chaussain C, Brandi ML, Savendahl L, Briot K, Kamenicky P, Rejnmark L, Linglart A.

Nat Rev Nephrol. 2019 Jul;15(7):435-455. doi: 10.1038/s41581-019-0152-5. Review.

PMID:
31068690
9.

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial.

Schaefer F, Mekahli D, Emma F, Gilbert RD, Bockenhauer D, Cadnapaphornchai MA, Shi L, Dandurand A, Sikes K, Shoaf SE.

Eur J Pediatr. 2019 Jul;178(7):1013-1021. doi: 10.1007/s00431-019-03384-x. Epub 2019 May 3.

10.

Cardiac Abnormalities in Children with Autosomal Recessive Polycystic Kidney Disease.

Chinali M, Lucchetti L, Ricotta A, Esposito C, D'Anna C, Rinelli G, Emma F, Massella L.

Cardiorenal Med. 2019;9(3):180-189. doi: 10.1159/000496473. Epub 2019 Mar 7.

PMID:
30844805
11.

Intrinsic Bone Defects in Cystinotic Mice.

Battafarano G, Rossi M, Rega LR, Di Giovamberardino G, Pastore A, D'Agostini M, Porzio O, Nevo N, Emma F, Taranta A, Del Fattore A.

Am J Pathol. 2019 May;189(5):1053-1064. doi: 10.1016/j.ajpath.2019.01.015. Epub 2019 Feb 19.

PMID:
30794806
12.

Treatment and long-term outcome in primary distal renal tubular acidosis.

Lopez-Garcia SC, Emma F, Walsh SB, Fila M, Hooman N, Zaniew M, Bertholet-Thomas A, Colussi G, Burgmaier K, Levtchenko E, Sharma J, Singhal J, Soliman NA, Ariceta G, Basu B, Murer L, Tasic V, Tsygin A, Decramer S, Gil-Peña H, Koster-Kamphuis L, La Scola C, Gellermann J, Konrad M, Lilien M, Francisco T, Tramma D, Trnka P, Yüksel S, Caruso MR, Chromek M, Ekinci Z, Gambaro G, Kari JA, König J, Taroni F, Thumfart J, Trepiccione F, Winding L, Wühl E, Ağbaş A, Belkevich A, Vargas-Poussou R, Blanchard A, Conti G, Boyer O, Dursun I, Pınarbaşı AS, Melek E, Miglinas M, Novo R, Mallett A, Milosevic D, Szczepanska M, Wente S, Cheong HI, Sinha R, Gucev Z, Dufek S, Iancu D; European dRTA Consortium , Kleta R, Schaefer F, Bockenhauer D.

Nephrol Dial Transplant. 2019 Jun 1;34(6):981-991. doi: 10.1093/ndt/gfy409.

PMID:
30773598
13.

Levamisole for children with nephrotic syndrome: new evidence for the use of an "old" drug.

Vivarelli M, Emma F.

Kidney Int. 2019 Jan;95(1):25-28. doi: 10.1016/j.kint.2018.10.008.

PMID:
30606425
14.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
15.

Renal Tubular Dysfunction Fully Accounts for Plasma Biochemical Abnormalities in Type 1A Pseudohypoparathyroidism.

Labbadia R, Bizzarri C, Mucciolo M, Di Zazzo G, Guzzo I, Cappa M, Emma F, Dello Strologo L.

J Clin Endocrinol Metab. 2019 Mar 1;104(3):823-826. doi: 10.1210/jc.2018-01193.

PMID:
30418563
16.

Impaired urinary concentration ability is a sensitive predictor of renal disease progression in Joubert syndrome.

Nuovo S, Fuiano L, Micalizzi A, Battini R, Bertini E, Borgatti R, Caridi G, D'Arrigo S, Fazzi E, Fischetto R, Ghiggeri GM, Giordano L, Leuzzi V, Romaniello R, Signorini S, Stringini G, Zanni G, Romani M, Valente EM, Emma F.

Nephrol Dial Transplant. 2018 Nov 6. doi: 10.1093/ndt/gfy333. [Epub ahead of print]

PMID:
30403813
17.

Equations to estimate prednisone dose using body weight.

Emma F, Montini G, Gargiulo A.

Pediatr Nephrol. 2019 Apr;34(4):685-688. doi: 10.1007/s00467-018-4127-8. Epub 2018 Oct 27.

PMID:
30368613
18.

FGF23 blockade coming to clinical practice.

Emma F, Haffner D.

Kidney Int. 2018 Nov;94(5):846-848. doi: 10.1016/j.kint.2018.08.022. No abstract available.

PMID:
30348298
19.

B cell phenotype in pediatric idiopathic nephrotic syndrome.

Colucci M, Carsetti R, Cascioli S, Serafinelli J, Emma F, Vivarelli M.

Pediatr Nephrol. 2019 Jan;34(1):177-181. doi: 10.1007/s00467-018-4095-z. Epub 2018 Sep 28.

PMID:
30267238
20.

Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome.

Debiec H, Dossier C, Letouzé E, Gillies CE, Vivarelli M, Putler RK, Ars E, Jacqz-Aigrain E, Elie V, Colucci M, Debette S, Amouyel P, Elalaoui SC, Sefiani A, Dubois V, Simon T, Kretzler M, Ballarin J, Emma F, Sampson MG, Deschênes G, Ronco P.

J Am Soc Nephrol. 2018 Jul;29(7):2000-2013. doi: 10.1681/ASN.2017111185. Epub 2018 Jun 14.

21.

Prevalence of Hypertension in Children with Early-Stage ADPKD.

Massella L, Mekahli D, Paripović D, Prikhodina L, Godefroid N, Niemirska A, Ağbaş A, Kalicka K, Jankauskiene A, Mizerska-Wasiak M, Afonso AC, Salomon R, Deschênes G, Ariceta G, Özçakar ZB, Teixeira A, Duzova A, Harambat J, Seeman T, Hrčková G, Lungu AC, Papizh S, Peco-Antic A, De Rechter S, Giordano U, Kirchner M, Lutz T, Schaefer F, Devuyst O, Wühl E, Emma F.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):874-883. doi: 10.2215/CJN.11401017. Epub 2018 Apr 19.

22.

Impact of atypical mitochondrial cyclic-AMP level in nephropathic cystinosis.

Bellomo F, Signorile A, Tamma G, Ranieri M, Emma F, De Rasmo D.

Cell Mol Life Sci. 2018 Sep;75(18):3411-3422. doi: 10.1007/s00018-018-2800-5. Epub 2018 Mar 16.

PMID:
29549422
23.

Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome.

Starc N, Li M, Algeri M, Conforti A, Tomao L, Pitisci A, Emma F, Montini G, Messa P, Locatelli F, Bernardo ME, Vivarelli M.

Cytotherapy. 2018 Mar;20(3):322-334. doi: 10.1016/j.jcyt.2017.12.001. Epub 2017 Dec 29.

PMID:
29291917
24.

Oligonephronia and Wolf-Hirschhorn syndrome: A further observation.

Gatto A, Ferrara P, Leoni C, Onesimo R, Zollino M, Emma F, Zampino G.

Am J Med Genet A. 2018 Feb;176(2):409-414. doi: 10.1002/ajmg.a.38554. Epub 2017 Nov 28.

PMID:
29193639
25.

A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.

Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC; all members of the Levamisole Study Group.

Kidney Int. 2018 Feb;93(2):510-518. doi: 10.1016/j.kint.2017.08.011. Epub 2017 Oct 18.

26.

The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

De Matteis MA, Staiano L, Emma F, Devuyst O.

Nat Rev Nephrol. 2017 Aug;13(8):455-470. doi: 10.1038/nrneph.2017.83. Epub 2017 Jul 3. Review.

PMID:
28669993
27.

High-content drug screening for rare diseases.

Bellomo F, Medina DL, De Leo E, Panarella A, Emma F.

J Inherit Metab Dis. 2017 Jul;40(4):601-607. doi: 10.1007/s10545-017-0055-1. Epub 2017 Jun 7. Review.

PMID:
28593466
28.

Mitochondrial cytopathies and the kidney.

Emma F, Salviati L.

Nephrol Ther. 2017 Apr;13 Suppl 1:S23-S28. doi: 10.1016/j.nephro.2017.01.014. Review.

PMID:
28577739
29.

Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children.

Trautmann A, Schnaidt S, Lipska-Ziętkiewicz BS, Bodria M, Ozaltin F, Emma F, Anarat A, Melk A, Azocar M, Oh J, Saeed B, Gheisari A, Caliskan S, Gellermann J, Higuita LMS, Jankauskiene A, Drozdz D, Mir S, Balat A, Szczepanska M, Paripovic D, Zurowska A, Bogdanovic R, Yilmaz A, Ranchin B, Baskin E, Erdogan O, Remuzzi G, Firszt-Adamczyk A, Kuzma-Mroczkowska E, Litwin M, Murer L, Tkaczyk M, Jardim H, Wasilewska A, Printza N, Fidan K, Simkova E, Borzecka H, Staude H, Hees K, Schaefer F; PodoNet Consortium.

J Am Soc Nephrol. 2017 Oct;28(10):3055-3065. doi: 10.1681/ASN.2016101121. Epub 2017 May 31.

30.

Immunology of idiopathic nephrotic syndrome.

Colucci M, Corpetti G, Emma F, Vivarelli M.

Pediatr Nephrol. 2018 Apr;33(4):573-584. doi: 10.1007/s00467-017-3677-5. Epub 2017 Apr 27. Review.

PMID:
28451893
31.

The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse.

Pasini A, Benetti E, Conti G, Ghio L, Lepore M, Massella L, Molino D, Peruzzi L, Emma F, Fede C, Trivelli A, Maringhini S, Materassi M, Messina G, Montini G, Murer L, Pecoraro C, Pennesi M.

Ital J Pediatr. 2017 Apr 21;43(1):41. doi: 10.1186/s13052-017-0356-x. Review.

32.

The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis.

Palazzo V, Provenzano A, Becherucci F, Sansavini G, Mazzinghi B, Orlandini V, Giunti L, Roperto RM, Pantaleo M, Artuso R, Andreucci E, Bargiacchi S, Traficante G, Stagi S, Murer L, Benetti E, Emma F, Giordano M, Rivieri F, Colussi G, Penco S, Manfredini E, Caruso MR, Garavelli L, Andrulli S, Vergine G, Miglietti N, Mancini E, Malaventura C, Percesepe A, Grosso E, Materassi M, Romagnani P, Giglio S.

Kidney Int. 2017 May;91(5):1243-1255. doi: 10.1016/j.kint.2016.12.017. Epub 2017 Feb 21.

PMID:
28233610
33.

Minimal Change Disease.

Vivarelli M, Massella L, Ruggiero B, Emma F.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):332-345. doi: 10.2215/CJN.05000516. Epub 2016 Dec 9. Review.

34.

Nephrotic-Range Proteinuria and Peripheral Edema in a Child: Not Only Idiopathic Nephrotic Syndrome.

Dolcemascolo V, Vivarelli M, Colucci M, Diomedi-Camassei F, Piras R, Alberti M, Emma F.

Case Rep Nephrol Dial. 2016 Nov 1;6(3):120-127. eCollection 2016 Sep-Dec.

35.

Cystinosin-LKG rescues cystine accumulation and decreases apoptosis rate in cystinotic proximal tubular epithelial cells.

Taranta A, Bellomo F, Petrini S, Polishchuk E, De Leo E, Rega LR, Pastore A, Polishchuk R, De Matteis MA, Emma F.

Pediatr Res. 2017 Jan;81(1-1):113-119. doi: 10.1038/pr.2016.184. Epub 2016 Sep 22.

PMID:
27656773
36.

Erratum to: Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, Smerud HK, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.

Pediatr Nephrol. 2017 Jan;32(1):193-194. No abstract available.

37.

Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.

Vivarelli M, Colucci M, Bonanni A, Verzani M, Serafinelli J, Emma F, Ghiggeri G.

Pediatr Nephrol. 2017 Jan;32(1):181-184. Epub 2016 Sep 29.

PMID:
27687621
38.

Skeletal implications and management of cystinosis: three case reports and literature review.

Bacchetta J, Greco M, Bertholet-Thomas A, Nobili F, Zustin J, Cochat P, Emma F, Boivin G.

Bonekey Rep. 2016 Aug 17;5:828. doi: 10.1038/bonekey.2016.55. eCollection 2016. Review.

39.

Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.

Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.

Pediatr Nephrol. 2017 Jan;32(1):139-150. Epub 2016 Aug 25. Erratum in: Pediatr Nephrol. 2017 Jan;32(1):193-194.

40.

Outcome of childhood-onset full-house nephropathy.

Ruggiero B, Vivarelli M, Gianviti A, Pecoraro C, Peruzzi L, Benetti E, Ventura G, Pennesi M, Murer L, Coppo R, Emma F.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1194-1204. doi: 10.1093/ndt/gfw230.

PMID:
27270291
41.

Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Langman CB, Barshop BA, Deschênes G, Emma F, Goodyer P, Lipkin G, Midgley JP, Ottolenghi C, Servais A, Soliman NA, Thoene JG, Levtchenko EN; Conference Participants.

Kidney Int. 2016 Jun;89(6):1192-203. doi: 10.1016/j.kint.2016.01.033.

PMID:
27181776
42.

Carboxyl-Terminal SSLKG Motif of the Human Cystinosin-LKG Plays an Important Role in Plasma Membrane Sorting.

Bellomo F, Taranta A, Petrini S, Venditti R, Rocchetti MT, Rega LR, Corallini S, Gesualdo L, De Matteis MA, Emma F.

PLoS One. 2016 May 5;11(5):e0154805. doi: 10.1371/journal.pone.0154805. eCollection 2016.

43.

Activation of the transcription factor EB rescues lysosomal abnormalities in cystinotic kidney cells.

Rega LR, Polishchuk E, Montefusco S, Napolitano G, Tozzi G, Zhang J, Bellomo F, Taranta A, Pastore A, Polishchuk R, Piemonte F, Medina DL, Catz SD, Ballabio A, Emma F.

Kidney Int. 2016 Apr;89(4):862-73. doi: 10.1016/j.kint.2015.12.045.

PMID:
26994576
44.

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice.

Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G, Covic A, Devuyst O, Drechsler C, Eckardt KU, Emma F, Knebelmann B, Le Meur Y, Massy ZA, Ong AC, Ortiz A, Schaefer F, Torra R, Vanholder R, Więcek A, Zoccali C, Van Biesen W.

Nephrol Dial Transplant. 2016 Mar;31(3):337-48. doi: 10.1093/ndt/gfv456. Epub 2016 Jan 29. Review.

45.

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.

Iatropoulos P, Noris M, Mele C, Piras R, Valoti E, Bresin E, Curreri M, Mondo E, Zito A, Gamba S, Bettoni S, Murer L, Fremeaux-Bacchi V, Vivarelli M, Emma F, Daina E, Remuzzi G.

Mol Immunol. 2016 Mar;71:131-142. doi: 10.1016/j.molimm.2016.01.010. Epub 2016 Feb 16.

PMID:
26895476
46.

Mitochondrial dysfunction in inherited renal disease and acute kidney injury.

Emma F, Montini G, Parikh SM, Salviati L.

Nat Rev Nephrol. 2016 May;12(5):267-80. doi: 10.1038/nrneph.2015.214. Epub 2016 Jan 25. Review.

47.
48.

Cellular immune profile of kidney transplant patients developing anti-HLA antibodies during childhood.

Santilli V, Cagigi A, Guzzo I, Rinaldi S, Mora N, Zotta F, Piazza A, Rossi P, Emma F, Dello Strologo L, Palma P.

Pediatr Nephrol. 2016 Jun;31(6):1001-10. doi: 10.1007/s00467-015-3274-4. Epub 2015 Dec 21.

PMID:
26692023
49.

Left Ventricular Mass Indexing in Infants, Children, and Adolescents: A Simplified Approach for the Identification of Left Ventricular Hypertrophy in Clinical Practice.

Chinali M, Emma F, Esposito C, Rinelli G, Franceschini A, Doyon A, Raimondi F, Pongiglione G, Schaefer F, Matteucci MC.

J Pediatr. 2016 Mar;170:193-8. doi: 10.1016/j.jpeds.2015.10.085. Epub 2015 Dec 6. Erratum in: J Pediatr. 2016 Apr;171:323.

PMID:
26670053
50.

B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.

Colucci M, Carsetti R, Cascioli S, Casiraghi F, Perna A, Ravà L, Ruggiero B, Emma F, Vivarelli M.

J Am Soc Nephrol. 2016 Jun;27(6):1811-22. doi: 10.1681/ASN.2015050523. Epub 2015 Nov 13.

Supplemental Content

Support Center